Hjem › Blærekreft › Missouri › Cape Girardeau
Kliniske studier for Blærekreft i Cape Girardeau, MO
5 studier for Blærekreft søker deltakere på steder i og rundt Cape Girardeau (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
RekruttererFase 2
- Saint Francis Medical Center, Cape Girardeau
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Mercy Cancer Center - Cape Girardeau, Cape Girardeau
- Saint Francis Medical Center, Cape Girardeau
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
RekruttererFase 2
- Saint Francis Medical Center, Cape Girardeau
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekruttererFase 2
- Saint Francis Medical Center, Cape Girardeau
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
RekruttererFase 3
- Mercy Cancer Center - Cape Girardeau, Cape Girardeau
- Saint Francis Medical Center, Cape Girardeau
Blærekreft-studier i andre byer
- New York City, NY35 studier
- Nashville, TN31 studier
- Houston, TX31 studier
- Dallas, TX27 studier
- Washington, DC26 studier
- Boston, MA26 studier
- Baltimore, MD24 studier
- Los Angeles, CA24 studier
- St. Louis, MO22 studier
- Seattle, WA21 studier
- Chicago, IL21 studier
- Philadelphia, PA21 studier
Andre studier i Cape Girardeau
- Ikke-småcellet lungekreft9 studier
- Lungekreft8 studier
- Prostatakreft7 studier
- Plateepitelcancer i hode og hals6 studier
- Nyrekreft (nyrecellekarcinom)6 studier
- Hypofarynxcancer5 studier
- Larynxcancer5 studier
- Munnhulekreft5 studier
- Brystkreft4 studier
- Tykktarmskreft4 studier
- Kolorektal kreft4 studier
- Endetarmskreft3 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.